Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Phosphatidylcholine Biosynthetic Pathway encompasses the various routes by which phosphatidylcholine (PtdCho), a major membrane phospholipid, is synthesized in different organisms. Key pathways include the CDP-choline pathway (primarily in mammals), the CDP-diacylglycerol pathway (significant in yeast and hepatocytes), and the phospholipid N-methylation (PMT) and phosphatidylcholine synthase (PCS) pathways (used in bacteria). The pathway is crucial for membrane structure, signaling, and the production of other biomolecules. Dysregulation of this pathway is implicated in various diseases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphatidylcholine Biosynthetic Pathway (PtdCho Biosynthesis).